58 related articles for article (PubMed ID: 3224348)
21. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
[TBL] [Abstract][Full Text] [Related]
22. [Carcino-embryonic antigen in cases of cervical carcinoma (author's transl)].
Weppelmann B; Schulz BO; Oberheuser F
Zentralbl Gynakol; 1981; 103(21):1273-9. PubMed ID: 6275635
[TBL] [Abstract][Full Text] [Related]
23. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
[TBL] [Abstract][Full Text] [Related]
24. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
25. [Determination of circulating ectopic beta HCG in solid tumors (author's transl)].
Canal P; Bugat R; Soula G; Combes PF
Pathol Biol (Paris); 1981 Mar; 29(3):150-4. PubMed ID: 7017558
[TBL] [Abstract][Full Text] [Related]
26. Choriocarcinoma of the stomach.
Smith FR; Barkin JS; Hensley G
Am J Gastroenterol; 1980 Jan; 73(1):45-8. PubMed ID: 6990747
[TBL] [Abstract][Full Text] [Related]
27. Serum tumor markers in metastatic breast cancer and course of disease.
Caffier H; Brandau H
Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
[TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
29. Serum carcinoembryonic antigens in patients with carcinoma of the cervix.
Ito H; Kurihara S; Nishimura C
Obstet Gynecol; 1978 Apr; 51(4):468-71. PubMed ID: 566405
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
[TBL] [Abstract][Full Text] [Related]
32. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
Gajewska J; Ceran A; Chełchowska M; Borowski D; Ambroszkiewicz J; Jaczyńska R; Zwoliński J; Laskowska-Klita T
Przegl Lek; 2008; 65(10):479-82. PubMed ID: 19189527
[TBL] [Abstract][Full Text] [Related]
33. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of diagnostic usefulness of CEA, hCG and SCC antigens in cervical cancer patients.
Kornafel J; Wawrzkiewicz M
Eur J Gynaecol Oncol; 1989; 10(5):319-22. PubMed ID: 2806319
[TBL] [Abstract][Full Text] [Related]
36. [CEA, SP1 and HCG in serum and tissue homogenates of patients with gynecologic neoplasms].
Leyendecker G; Braun P; Itzbicki J; Neusel E
Arch Gynecol; 1979 Jul; 228(1-4):664-5. PubMed ID: 485550
[No Abstract] [Full Text] [Related]
37. Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin.
Waalkes TP; Gehrke CW; Tormey DC; Woo KB; Kuo KC; Synder J; Hansen H
Cancer; 1978 May; 41(5):1871-82. PubMed ID: 647632
[TBL] [Abstract][Full Text] [Related]
38. Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma.
Stone M; Bagshawe KD; Kardana A; Searle F; Dent J
Br J Obstet Gynaecol; 1977 May; 84(5):375-9. PubMed ID: 889730
[TBL] [Abstract][Full Text] [Related]
39. Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms.
Gailani S; Chu TM; Nussbaum A; Ostrander M; Christoff N
Cancer; 1976 Oct; 38(4):1684-6. PubMed ID: 991086
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous plasma determination of CEA, HCG-beta and beta-2-microglobulin in patients with nontrophoblastic tumors.
Ruibal A; Gultresa J
Tumori; 1980 Jun; 66(3):305-9. PubMed ID: 6160667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
